(Image credit: Illustration by Stephen Kelly / Getty Images)
By Joel Mathis, The Week US
published
The pharmacy industry is in crisis. That's especially true at CVS, where layoffs are piling on top of layoffs — and the future of the company is in question.
CVS Health announced this month that it is laying off 2,000 workers, CNN said, as part of an effort to "slash costs" across the company. That's on top of the 5,000 layoffs it announced last year, and after the company closed around 900 stores in recent years. CVS and other drug store chains are "struggling" due to falling reimbursement rates for prescription drugs, CNN said. "Our industry faces continued disruption, regulatory pressures and evolving consumer needs and expectations," said a company spokesperson.
CVS' problems are also "very specific to the company," said Axios. In addition to its pharmacies, CVS is also a "major insurer" — it bought Aetna in 2017 — as well as a pharmacy benefit manager. Yes, "retail pharmacy in general is struggling," but CVS' challenges "could just be the specific businesses it has combined," Axios said. That's why company leaders are reportedly considering breaking up those businesses — an extraordinary move in an era where "vertical integration is all the rage."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Satisfaction with brick-and-mortar pharmacies dropped 10 points in 2024," said Time. Customers report short-staffed outlets with "long lines and frustrating experiences." It's not just CVS: Rite Aid recently emerged from bankruptcy, and Walgreens is planning to close one-fourth of its roughly 8,600 stores. Customers simply didn't return to brick-and-mortar stores after the pandemic, preferring cheaper online alternatives. "The current pharmacy model is not sustainable," Walgreens CEO Tim Wentworth said in June.
That affects communities. The mass closure of retail pharmacies is a "growing worry for health experts," said the Missouri Independent. The problem is "most acute" in places with low incomes — "urban cores" and rural areas where pharmacies are the "convenience stores of the health care system." That makes getting necessary medications a growing challenge for the people who live in those places. "When those community pharmacies close, communities lose critical access," said one expert.
One other factor in the struggles of CVS and its industry: "Heavy competition" from Amazon and Walmart, said the Los Angeles Times. Pharmacy benefit managers (PBMs) also play a role — they have "significant control" over how much insurers pay pharmacies for medications and have worked to push down those reimbursement costs. That pushes down pharmacy profitability. One irony: CVS owns Caremark, a PBM. "That's made the drug retail business more healthy," said one analyst — but it still hasn't made CVS "immune to market forces," said the Times.
What next?
CVS' board is looking at "splitting the company," said The Wall Street Journal. That could be difficult. The spun-off businesses "might struggle to flourish on their own." The mergers with Aetna and Caremark were supposed to "bring down costs and give patients more convenient, accessible care." That didn't pan out. Now the future of the company is in limbo, the Journal said: CVS' board "isn't expected to make a decision soon."
Explore More
To continue reading this article...
Create a free account
Continue reading this article and get limited website access each month.
register for free
Already have an account? Sign in
Subscribe to The Week
Get unlimited website access, exclusive newsletters plus much more.
Subscribe & Save
Cancel or pause at any time.
Already a subscriber to The Week?
Unlimited website access is included with Digital and Print + Digital subscriptions.
Create an account with the same email registered to your subscription to unlock access.
Not sure which email you used for your subscription? Contact us
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joel Mathis, The Week US
Joel Mathis is a writer with 30 years of newspaper and online journalism experience. His work also regularly appears in National Geographic and The Kansas City Star. His awards include best online commentary at the Online News Association and (twice) at the City and Regional Magazine Association.
How Britain's demographic is changingA 50-year record population increase was fuelled by greater migrationBy Richard Windsor, The Week UKPublished 10 October 24 The story of Japanese jeweller TasakiThe BlendA revival in the use of pearls in fashion and jewellery design places heritage brand Tasaki centre stageBy Felix BischofPublished 10 October 24 The world's most beautiful gardensThe BlendFor the last word in gardening leave, our pick of the best scent-filled staysBy Delilah KhomoPublished 10 October 24
The 'game-changing' treatment for schizophreniaThe ExplainerUS poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effectsBy Harriet Marsden, The Week UKPublished 24 September 24 The audio industry is working to tackle hearing aid stigmaThe ExplainerOnly 1 in 5 people who could benefit from hearing aids use them, according to the Hearing Loss Association of AmericaBy Justin Klawans, The Week USPublished 23 September 24 Mold, bugs at listeria-linked Boar's Head meat plantSpeed ReadFood safety inspectors reported many violations at a Virginia plant that has been linked to a nationwide deli meat recallBy Peter Weber, The Week USPublished 30 August 24 FDA OKs new Covid vaccine, available soonSpeed readThe CDC recommends the new booster to combat the widely-circulating KP.2 strainBy Peter Weber, The Week USPublished 23 August 24 The battle for abortion buffer zonesThe ExplainerA 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'By Harriet Marsden, The Week UKPublished 20 August 24 WHO declares mpox a global health emergencySpeed ReadAn outbreak of the viral disease formerly known as monkeypox continues to spread in AfricaBy Rafi Schwartz, The Week USPublished 15 August 24 Why gonorrhoea is becoming 'untreatable'In the SpotlightInfections hit record high as experts warn about rise in antibiotic-resistant casesBy Elizabeth Carr-Ellis, The Week UKPublished 15 August 24 Where does MDMA-assisted therapy go from here?Today's Big QuestionPsychedelic treatments face a challenge from the FDABy Joel Mathis, The Week USPublished 15 August 24